The role of cellular flice inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer

被引：44

作者：

Dutton, A ^{[1
]}

Young, LS ^{[1
]}

Murray, PG ^{[1
]}

机构：

[1] Univ Birmingham, Sch Med, Dept Pathol, Canc Res UK Inst Canc Studies,Div Canc Studies, Birmingham B15 2TT, W Midlands, England

来源：

EXPERT OPINION ON THERAPEUTIC TARGETS | 2006年 / 10卷 / 01期

关键词：

cellular flice inhibitory protein (c-FLIP); gene therapy; Hodgkin's lymphoma (HL); RNA interference;

D O I：

10.1517/14728222.10.1.27

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Protection from death receptor (DR)-mediated apoptosis has been proposed as an important step in the development of malignancy, enabling tumour cells not only to survive and escape antitumour immune responses, but also to develop resistance to chemotherapy or other cancer treatments. An important regulator of DR-induced death is the cellular FADD-like IL-1 beta-converting enzyme inhibitory protein (c-FLIP) which, when overexpressed, can protect tumour cells from apoptosis. This review focuses on the role of c-FLIP as a tumour progression factor, with particular emphasis on recent work from the authors' laboratory concerning the contribution of c-FLIP to the pathogenesis of Hodgkin's lymphoma. The possibility of targeting c-FLIP as an approach to the treatment of cancer and, in particular, Hodgkin's lymphoma is discussed.

引用

页码：27 / 35

页数：9

共 98 条

[31] BH3-Only proteins - Essential initiators of apoptotic cell death [J].

Huang, DCS ;

Strasser, A .

CELL, 2000, 103 (06) :839-842

[32] Death and anti-death: Tumour resistance to apoptosis [J].

Igney, FH ;

Krammer, PH .

NATURE REVIEWS CANCER, 2002, 2 (04) :277-288

[33] CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis [J].

Inohara, N ;

Koseki, T ;

Hu, YM ;

Chen, S ;

Nunez, G .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10717-10722

[34] Inhibition of death receptor signals by cellular FLIP [J].

Irmler, M ;

Thome, M ;

Hahne, M ;

Schneider, P ;

Hofmann, B ;

Steiner, V ;

Bodmer, JL ;

Schroter, M ;

Burns, K ;

Mattmann, C ;

Rimoldi, D ;

French, LE ;

Tschopp, J .

NATURE, 1997, 388 (6638) :190-195

[35] THE POLYPEPTIDE ENCODED BY THE CDNA FOR HUMAN CELL-SURFACE ANTIGEN FAS CAN MEDIATE APOPTOSIS [J].

ITOH, N ;

YONEHARA, S ;

ISHII, A ;

YONEHARA, M ;

MIZUSHIMA, S ;

SAMESHIMA, M ;

HASE, A ;

SETO, Y ;

NAGATA, S .

CELL, 1991, 66 (02) :233-243

[36] Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells [J].

Kanzler, H ;

Kuppers, R ;

Hansmann, ML ;

Rajewsky, K .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1495-1505

[37] RNA interference and potential therapeutic applications of short interfering RNAs [J].

Karagiannis, TC ;

El-Osta, A .

CANCER GENE THERAPY, 2005, 12 (10) :787-795

[38] N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-κB signaling pathway [J].

Kataoka, T ;

Tschopp, J .

MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (07) :2627-2636

[39] The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways [J].

Kataoka, T ;

Budd, RC ;

Holler, N ;

Thome, M ;

Martinon, F ;

Irmler, M ;

Burns, K ;

Hahne, M ;

Kennedy, N ;

Kovacsovics, M ;

Tschopp, J .

CURRENT BIOLOGY, 2000, 10 (11) :640-648

[40]

Kehry MR, 1996, J IMMUNOL, V156, P2345

← 1 2 3 4 5 6 7 8 9 10 →